Table 1 Age, body mass index and baseline, 6- and 12-month biochemistry in transgender women and transgender men
From: Gender-affirming hormone therapy induces specific DNA methylation changes in blood
| Â | Transgender Women (n=13)Â (TW) | Transgender Men (n=13)Â (TM) |
|---|---|---|
Age (years) | 29.0 (22.0, 61.0) | 23.0 (21.0, 24.0) |
BMI (kg/m²) | 24.2 (22.3, 24.6) | 22.8 (21.8, 30.5) |
|  | Baseline (TW) | 6 months (TW) | 12 months (TW) | Baseline (TM) | 6 months (TM) | 12 months (TM) |
|---|---|---|---|---|---|---|
Biochemistry | Â | Â | Â | Â | Â | Â |
FSH (IU/L) | 5.2 (2.6, 7.4) | 0.8 (0.1, 1.2) | 0.2 (0.1, 0.8) | 6.4 (3.3, 7.2) | 5.4 (4.9, 6.3) | 4.1 (3.5, 5.4) |
LH (IU/L) | 6.1 (5.4, 6.7) | 2.0 (0.1, 3.9) | 0.1 (0.1, 2.2) | 7.5 (5.9, 8.3) | 7.2 (6.2, 10.0) | 4.7 (2.1, 7.0) |
E2 (pmol/L) | 56.0 (50.0, 76.0) | 259.0 (196.0,393.0) | 340.0 (294.0, 419.0) | 210.0 (90.5, 460.5) | 165.0 (92.0, 171.0) | 157.0 (120.0, 197.0) |
T (nmol/L) | 19.6 (19.8, 20.4) | 0.7 (0.4, 1.6) | 0.5 (0.4, 0.7) | 1.6 (1.2, 1.7) | 20.9 (15.3, 27.1) | 20.4 (17.5, 29.2) |
SHBG (nmol/L) | 51.0 (43.5, 54.0) | 74.0 (49.0, 105.0) | 76.0 (53.0, 98.0) | 51.0 (39.5, 74.5) | 37.0 (21.0, 56.0) | 33.0 (23.0, 62.0) |